These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9036472)

  • 21. Clinical implications of the "Multicenter Automatic Defibrillator Implantation Trial" (MADIT).
    Nisam S; Adragão P
    Rev Port Cardiol; 1997 Apr; 16(4):359-64, 351. PubMed ID: 9180060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardiac defibrillators.
    Spivack C
    N Engl J Med; 2002 Aug; 347(5):365-7; author reply 365-7. PubMed ID: 12154817
    [No Abstract]   [Full Text] [Related]  

  • 24. [The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E
    Ital Heart J Suppl; 2000 Apr; 1(4):577-8. PubMed ID: 10832149
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of arrhythmias after myocardial infarction in the post-CAST era.
    Camm AJ; Kautzner J
    Can J Cardiol; 1996 Apr; 12 Suppl B():9B-19B; discussion 27B-28B. PubMed ID: 8616727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
    Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiac arrhythmia suppression trial (CAST)].
    Furlanello F
    G Ital Cardiol; 1990 Feb; 20(2):171-6. PubMed ID: 2109715
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.
    Jafri SM; Borzak S; Goldberger J; Gheorghiade M
    Prog Cardiovasc Dis; 1998; 41(1):65-70. PubMed ID: 9717860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator.
    Prystowsky EN
    Rev Cardiovasc Med; 2003; 4 Suppl 2():S47-54. PubMed ID: 12776013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R; Cinca J; Marber M
    Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular news. AMIOVIRT.
    SoRelle R
    Circulation; 2000 Dec; 102(25):E9050-1. PubMed ID: 11120713
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of pharmacologic treatment to prevent sudden death in the implantable cardioverter defibrillator era.
    Elliott PM
    Curr Cardiol Rep; 2001 Mar; 3(2):167-72. PubMed ID: 11177676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary prevention of sudden cardiac death: the time of your life.
    Prystowsky EN
    Circulation; 2004 Mar; 109(9):1073-5. PubMed ID: 15007016
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of sudden death after myocardial infarction: should the "MADIT" strategy be generally applied? Arguments against].
    Arenal Maíz A
    Rev Esp Cardiol; 1997 Jul; 50(7):464-6. PubMed ID: 9304172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Norris RM
    Lancet; 1997 Jun; 349(9067):1767. PubMed ID: 9193396
    [No Abstract]   [Full Text] [Related]  

  • 37. Who are the MADIT patients? Multicenter Automatic Defibrillator Implantation Trial.
    Higgins SL; Daubert JL; Akhtar M
    Am J Cardiol; 1997 Sep; 80(5B):42F-46F. PubMed ID: 9291449
    [No Abstract]   [Full Text] [Related]  

  • 38. Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
    Tuna JL; Correia MJ; d'Almeida VC; Mourão L; da Costa FL; Ribeiro C
    Acta Med Port; 1980 Dec; Suppl 1():27-32. PubMed ID: 6164252
    [No Abstract]   [Full Text] [Related]  

  • 39. Designing clinical trials in the post CAST era--where do we go from here?
    Dorian P
    Can J Cardiol; 1991 Mar; 7(2):105-7; discussion 110-2. PubMed ID: 2049682
    [No Abstract]   [Full Text] [Related]  

  • 40. Life and death after ICD implantation.
    Healey J; Connolly S
    N Engl J Med; 2008 Sep; 359(10):1058-9. PubMed ID: 18768951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.